These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19017509)

  • 1. Coenzyme Q10: an independent predictor of mortality in chronic heart failure.
    Molyneux SL; Florkowski CM; George PM; Pilbrow AP; Frampton CM; Lever M; Richards AM
    J Am Coll Cardiol; 2008 Oct; 52(18):1435-41. PubMed ID: 19017509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
    J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated glomerular filtration rate is an independent predictor for mortality of patients with acute heart failure.
    Takagi A; Iwama Y; Yamada A; Aihara K; Daida H
    J Cardiol; 2010 May; 55(3):317-21. PubMed ID: 20350524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coenzyme Q10 changes are associated with metabolic syndrome.
    Miles MV; Morrison JA; Horn PS; Tang PH; Pesce AJ
    Clin Chim Acta; 2004 Jun; 344(1-2):173-9. PubMed ID: 15149886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.
    Kistorp C; Faber J; Galatius S; Gustafsson F; Frystyk J; Flyvbjerg A; Hildebrandt P
    Circulation; 2005 Sep; 112(12):1756-62. PubMed ID: 16157772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating erythropoietin levels and prognosis in patients with congestive heart failure: comparison with neurohormonal and inflammatory markers.
    George J; Patal S; Wexler D; Abashidze A; Shmilovich H; Barak T; Sheps D; Keren G
    Arch Intern Med; 2005 Jun; 165(11):1304-9. PubMed ID: 15956012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
    Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
    J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure.
    Perna ER; Macin SM; Cimbaro Canella JP; Szyszko A; Franciosi V; Vargas Morales W; Bayol AP; Kriskovich JO; Medina F; Gonzalez Arjol B; Brizuela M
    J Heart Lung Transplant; 2006 Oct; 25(10):1230-40. PubMed ID: 17045936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure.
    Tsutamoto T; Tanaka T; Sakai H; Ishikawa C; Fujii M; Yamamoto T; Horie M
    Eur Heart J; 2007 Jul; 28(14):1723-30. PubMed ID: 17507366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline low-density lipoprotein cholesterol levels and outcome in patients with heart failure.
    Charach G; George J; Roth A; Rogowski O; Wexler D; Sheps D; Grosskopf I; Weintraub M; Keren G; Rubinstein A
    Am J Cardiol; 2010 Jan; 105(1):100-4. PubMed ID: 20102899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department.
    Januzzi JL; Sakhuja R; O'donoghue M; Baggish AL; Anwaruddin S; Chae CU; Cameron R; Krauser DG; Tung R; Camargo CA; Lloyd-Jones DM
    Arch Intern Med; 2006 Feb; 166(3):315-20. PubMed ID: 16476871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure.
    Zairis MN; Tsiaousis GZ; Georgilas AT; Makrygiannis SS; Adamopoulou EN; Handanis SM; Batika PC; Prekates AA; Velissaris D; Kouris NT; Mytas DZ; Babalis DK; Karidis KS; Foussas SG
    Int J Cardiol; 2010 Jun; 141(3):284-90. PubMed ID: 19157603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of soluble receptor for advanced glycation end products to predict mortality in patients with chronic heart failure independently of Seattle Heart Failure Score.
    Raposeiras-Roubín S; Rodiño-Janeiro BK; Grigorian-Shamagian L; Moure-González M; Seoane-Blanco A; Varela-Román A; Almenar-Bonet L; Alvarez E; González-Juanatey JR
    Am J Cardiol; 2011 Mar; 107(6):938-44. PubMed ID: 21247530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of formulas estimating excretory renal function in the elderly with systolic heart failure.
    Scrutinio D; Passantino A; Santoro D; Cacciapaglia E; Farinola G
    Age Ageing; 2009 May; 38(3):296-301. PubMed ID: 19252204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of serum total cholesterol, C-reactive protein levels, and statin therapy to survival in heart failure.
    May HT; Muhlestein JB; Carlquist JF; Horne BD; Bair TL; Campbell BA; Kfoury AG; Lyon JL; Kim H; Renlund DG
    Am J Cardiol; 2006 Sep; 98(5):653-8. PubMed ID: 16923455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.
    Kubler P; Jankowska EA; Majda J; Reczuch K; Banasiak W; Ponikowski P
    Int J Cardiol; 2008 Oct; 129(3):373-8. PubMed ID: 18054808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure.
    van der Meer P; Voors AA; Lipsic E; Smilde TD; van Gilst WH; van Veldhuisen DJ
    J Am Coll Cardiol; 2004 Jul; 44(1):63-7. PubMed ID: 15234408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.